semaglutide being pulled from market GLP-1 weight-loss drugs may also curb alcohol cravings The Semaglutide Shortage Is Ending:

Randomized clinical trial (2025): A double-blind RCT found once-weekly semaglutide reduced alcohol craving and heavy drinking versus placebo in adults with AUD, supporting larger confirmatory trials

LTP was almost at the same level as wild-type controls (see Figure 4)

Li Y, Gappy S, Liu X, Sassalos T, Zhou T, Hsu A, et al

RESEARCH STUDIES MT-1 Research Applications & Published Studies MT-1 research spans over three decades of published literature across preclinical and clinical research contexts

Mechanistic Focus in Research Within experimental laboratory settings, Tesamorelin / Ipamorelin is commonly studied in relation to peptide-mediated signalling pathways

The severity and frequency of side effects vary